- Home
- CMPR vs SLNO Comparison
CMPR vs SLNO Comparison
Compare CMPR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMPR | SLNO |
|---|---|---|
| Founded | 1994 | 1999 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.5B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CMPR | SLNO |
|---|---|---|
| Price | $75.75 | $49.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $80.50 | ★ $110.90 |
| AVG Volume (30 Days) | 178.0K | ★ 1.6M |
| Earning Date | 01-28-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $3,461,387,000.00 | $98,675,000.00 |
| Revenue This Year | $8.23 | N/A |
| Revenue Next Year | $4.83 | $155.86 |
| P/E Ratio | $54.64 | ★ N/A |
| Revenue Growth | ★ 3.65 | N/A |
| 52 Week Low | $35.21 | $41.50 |
| 52 Week High | $82.40 | $90.32 |
Technical Indicators
Market Signals| Indicator | CMPR | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 65.01 | 46.19 |
| Support Level | $69.18 | $48.60 |
| Resistance Level | $75.17 | $55.47 |
| Average True Range (ATR) | 2.68 | 2.79 |
| MACD | 0.43 | 0.67 |
| Stochastic Oscillator | 93.24 | 42.12 |
Price Performance
Historical ComparisonAbout CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.